Business Wire11.09.21
Outset Medical Inc., a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, has appointed Nabeel Ahmed, as chief financial officer (CFO). He was serving as Outset’s interim CFO since July 16, 2021.
“Nabeel’s extensive experience across a variety of finance roles and his tenure as a leader at Outset give me great confidence in his ability to lead as chief financial officer,” said Leslie Trigg, president and CEO. “I look forward to working closely with him as a member of the executive team as we continue to execute on our mission while delivering meaningful shareholder and stakeholder value.”
Nabeel joined Outset in May 2020 as the company’s vice president, Controller, and has served as interim CFO since mid-July. Prior to joining the company, Nabeel served as vice president, Finance, at 8x8 Inc., a communications platform provider and as vice president, Finance, at Vocera Communications Inc. Previously, he held various leadership positions in accounting and finance, including as CFO of Wanderful Media as well as CFO of MarketTools Inc. Earlier in his career, Nabeel held various positions of increasing responsibility at Ernst & Young LLP and eBay Inc.
Ahmed earned a bachelor of commerce degree from Laurentian University and an MBA from The Wharton School, University of Pennsylvania.
“I am thrilled to step into this role at such an exciting time for Outset,” said Ahmed. “Our team, technology, and growth potential position us uniquely and I look forward to working toward continued success as we further scale commercially and operationally.”
Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, U.S. Food and Drug Administration-cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with two-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical Inc.
“Nabeel’s extensive experience across a variety of finance roles and his tenure as a leader at Outset give me great confidence in his ability to lead as chief financial officer,” said Leslie Trigg, president and CEO. “I look forward to working closely with him as a member of the executive team as we continue to execute on our mission while delivering meaningful shareholder and stakeholder value.”
Nabeel joined Outset in May 2020 as the company’s vice president, Controller, and has served as interim CFO since mid-July. Prior to joining the company, Nabeel served as vice president, Finance, at 8x8 Inc., a communications platform provider and as vice president, Finance, at Vocera Communications Inc. Previously, he held various leadership positions in accounting and finance, including as CFO of Wanderful Media as well as CFO of MarketTools Inc. Earlier in his career, Nabeel held various positions of increasing responsibility at Ernst & Young LLP and eBay Inc.
Ahmed earned a bachelor of commerce degree from Laurentian University and an MBA from The Wharton School, University of Pennsylvania.
“I am thrilled to step into this role at such an exciting time for Outset,” said Ahmed. “Our team, technology, and growth potential position us uniquely and I look forward to working toward continued success as we further scale commercially and operationally.”
Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, U.S. Food and Drug Administration-cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with two-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical Inc.